We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

PCR Biosystems Launches RiboShield™ RNase Inhibitor

Product News   Sep 16, 2020

 
PCR Biosystems Launches RiboShield™ RNase Inhibitor
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Leinco Technologies Launches ImmunoRank™ Neutralization MICRO-ELIZA for COVID-19

Product News

A new ELISA test has been developed to aid in the analysis of identifying neutralizing antibodies towards SARS-CoV-2.

READ MORE

Phase 1 Clinical Trial of COVID-19 Vaccine UB-612 Initiates in Taiwan

Product News

The first volunteers have been safely dosed in COVAXX's Phase 1, open-label, dose-escalation study of the UB-612 vaccine candidate for COVID-19 in Taiwan.

READ MORE

New Collaboration Explores Efficacy of Gene Delivery Vector Tech in Diabetes and Multiple Sclerosis

Product News

Amarna Therapeutics has announced today that it has entered into a collaboration with scientists from the Progreso y Salud Foundation (FPS) at Cabimer in Seville, to jointly examine the efficacy of Amarna’s SVec™ gene delivery vector for the development of effective immunotherapies for diabetes mellitus type 1 (DM1) and multiple sclerosis (MS).

READ MORE

Like what you just read? You can find similar content on the communities below.

Genomics Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE